WuXi AppTec Co., Ltd. (603259.SS)

Shanghai · Healthcare · Diagnostics & Research
140.80 CNY-2.49%As of 2026-11-22 · CNY
Last session low 137.52 CNYLast session high 141.98 CNY
52-week low 87.09 CNY52-week high 173.60 CNY
Market cap (USD)
$64.00B
Sector
Healthcare
P/E (TTM)
15.7x
Dividend yield
1.48%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in CNY.

IndicatorValueReading
RSI (14)41.5In the neutral range (30 to 70)
MACD (12, 26, 9)-1.77Below its signal line (-1.64); histogram -0.13
Bollinger %B (20, 2)25%Inside the bands (136.34 to 154.13)
SMA 20145.23Price is 3.1% below
SMA 50151.88Price is 7.3% below
SMA 200121.96Price is 15.4% above
ATR (20)4.93% of priceAverage true range per day
52-week position62%In the middle of the 87.09 to 173.60 range

About WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments.

Latest fiscal yearEnded 2025-12-31: revenue of 45.46B CNY and an operating margin of 37.4%.

Also listed as 2359.HK (HKSE)

More in Diagnostics & Research